| Dr Jeremy Cole, MD | |
|
105 S Bryant Ave, Suite 204b, Edmond, OK 73034-6399 | |
| (405) 844-5200 | |
| Not Available |
| Full Name | Dr Jeremy Cole |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 51 Years |
| Location | 105 S Bryant Ave, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962586701 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 23251 (Oklahoma) | Secondary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 23251 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Integris Health Edmond | Edmond, OK | Hospital |
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Entity Name | Jeremy Cole Md, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982774428 PECOS PAC ID: 9638150667 Enrollment ID: O20040526000819 |
News Archive
Autopsies of nearly every patient with the lethal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), and many with frontotemporal dementia (FTD), show pathologists telltale clumps of a protein called TDP-43. Now, working with mouse and human cells, Johns Hopkins researchers report they have discovered the normal role of TDP-43 in cells and why its abnormal accumulation may cause disease.
Bio-Matrix Scientific Group, Inc. provided a progress report on the Company's previously announced new opportunities. The Company has been moving forward in the areas of stem cell research for treatment of Chronic Obstructive Pulmonary Disease (COPD), Tumor Banking and Cancer Treatment.
Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.
› Verified 7 days ago
| Entity Name | Nextgen Sleep Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245605377 PECOS PAC ID: 8325311376 Enrollment ID: O20170913002373 |
News Archive
Autopsies of nearly every patient with the lethal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), and many with frontotemporal dementia (FTD), show pathologists telltale clumps of a protein called TDP-43. Now, working with mouse and human cells, Johns Hopkins researchers report they have discovered the normal role of TDP-43 in cells and why its abnormal accumulation may cause disease.
Bio-Matrix Scientific Group, Inc. provided a progress report on the Company's previously announced new opportunities. The Company has been moving forward in the areas of stem cell research for treatment of Chronic Obstructive Pulmonary Disease (COPD), Tumor Banking and Cancer Treatment.
Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeremy Cole, MD 105 S Bryant Ave, Suite 204b, Edmond, OK 73034-6399 Ph: (405) 844-5200 | Dr Jeremy Cole, MD 105 S Bryant Ave, Suite 204b, Edmond, OK 73034-6399 Ph: (405) 844-5200 |
News Archive
Autopsies of nearly every patient with the lethal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), and many with frontotemporal dementia (FTD), show pathologists telltale clumps of a protein called TDP-43. Now, working with mouse and human cells, Johns Hopkins researchers report they have discovered the normal role of TDP-43 in cells and why its abnormal accumulation may cause disease.
Bio-Matrix Scientific Group, Inc. provided a progress report on the Company's previously announced new opportunities. The Company has been moving forward in the areas of stem cell research for treatment of Chronic Obstructive Pulmonary Disease (COPD), Tumor Banking and Cancer Treatment.
Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.
› Verified 7 days ago
Viorica Khalili, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 S Bryant Ave, Suite 202, Edmond, OK 73034 Phone: 405-340-4565 Fax: 405-340-4583 | |
Dr. Royce Lee Bargas, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3839 S Boulevard Ste 100, Edmond, OK 73013 Phone: 405-607-4445 | |
Dr. Brian Levy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 124 N Bryant Ave, C4, Edmond, OK 73034 Phone: 405-330-7606 Fax: 405-330-7607 | |
Rakesh Shrivastava, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Bryant Ave Ste 101, Edmond, OK 73034 Phone: 405-861-0004 Fax: 855-680-8890 | |
Dr. Craig W Carson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Renaissance Blvd, Suite 110, Edmond, OK 73013 Phone: 405-844-4978 Fax: 405-844-0562 | |
Laurie Anne Orme, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E Waterloo Rd, Edmond, OK 73034 Phone: 405-715-2000 Fax: 405-715-2010 | |
Jeremy Brandon Moad, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Bryant Ave Ste 104, Edmond, OK 73034 Phone: 405-715-2022 Fax: 405-715-2905 |